Charity reglstrallon number NIC101345 Company reglstration number N1616925 (Northèrn lrnland) FRIENDS OF THE CANCER CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
FRIENDS OF THE CANCER CENTRE LEGALAND ADMINISTRATIVE INFORMATION Patrons Mr John Daly Mr Eamonn Holmes Mr lain Henderson Mr Denis Moloney Directors Mr B Cavè Ms C Aiken Dr D Flnnegan Prof S Jain Mr R Donnan Ms C Keenan Dr S McAleer ProfAAdair Mr P Mcmaw Mr J Rlce Prof M Durkln Mr Brlan Fee Mr D Cubbitt Dr Caroline Ford8 (Appolnted 9 June 2023) (Appointed 9 June 2023) (Appointed 15 September 2023) (Appolnted 23 F8bruary 20241 Secratary Ms C Keenan Charity number NIC101345 Company number N1616925 Reglstered office N.1. Cancer Centre Belfast Cily Hospiial Lisbum Road Belfast Co. Anlrim BT9 7AB Auditor Harblnson Mulholland C8ntrepoint 24 Omieau Avenue Belfast Co. Antrim Northern Ireland BT2 8HS Bankers Ulster Bank Llmited 11-16 Donegall Square East Belfast BT15UB
FRIENDS OF THE CANCER CENTRE CONTENTS Page Dlr8Ctors' report Stat8ment of Dlrectors, rasponsibilltles Independent auditorfs report ststement of financlal actlvlties 10 Statement of flnanclal position Statement of cash flows 13 Notes to the financlal statements 14-24
FRIENDS OF THE CANCER CENTRE DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT) FOR THE YEAR ENDED 31 MARCH 2024 The Directors present their annual report and financial staternents for the year ended 31 March 2024. The financial statements have been prepared in accordance with the accounting policies sel out in note 1 to the rinancial slaternents and comply with the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice appllcable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021" las amended for accountlng periods commencing from 1 January 20161 Objectlves and actlvitles The Charity operates in Northern Ireland and Its objectives are to support patients and their familiès by enhancing the quality of care they rèceive and contribute to canr care. treatment and research throughout Northern Ireland. Achlevament8 and performance During the year funds amounting to £1,165,205 were used to contrlbute to research, patient comfort, Clinical care and ¢ampaigns throughout Northern Ireland. These break down as follows.. Research Radiotherapy Physics Support Position 76% Radiotherapy, Research & Development Radiographer Patrick G. Johnston Centre for Cancer Research, N.1. Cancer Centre Trials Grant 17,233 64,180 342,058 423,471 Patlent Comfort Teenaga & Young Adults Group Programme North West Cancer Cent, Coffee Dock Supplies Social Work Granls, Nl Cancer Centre Drinks Machines, Nl Cancer Centre Support for Breast Health & W811 Belng Events Physiotherapy, Physical Activity Cancer Referral Coach Radiotherapy, Clothing for Patlents Social Work Grants, North West Cancer Centre Bridgewater Suite, Refreshments for Patients Macmillan Support & Informatlon Centre, Support & Wellbeing Programffle Radiotherapy, Refreshments for Patient Coffee Dock Radiotherapy, Children's Activity Gifts Garden Materials, Nl Canr Centre and Macmillan Support & Infomation Centre Ward 10 North Refurbishment of Dayroom AOHU Dayroom Refurbishment of Chairs Christmas Presents for Patients and Hampers for Staff Teenage & Young Adults, Christmas Vouchers Regional Support for Prostate Cancer Health & Wellbeing TV for Ward 2A Dayroorn 3,524 1,081 115,950 3,252 479 35,567 131 11,300 12,000 113,093 2,465 495 774 4,206 1,810 1,334 1,225 728 485 309,899
FRIENDS OF THE CANCER CENTRE DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Patlent Care North West Cancer Centre. Upper Gl Support Worker North West Cancer Centre, Upper Gl. Clinical Nurse Specialist North West Cancer Centre, Research & Development Radiographer Clinical Nurse Specialist, Secondary Breast Cancer Nurse Speech & Language Therapy Assistant Manager Library Books, Nl Cancer Centre Radiotherapy, Physics Support Posltlon 25D Occupatlonal Therapy, Pressure Reduclng Cushions Dletitian Clinical Specialist, Nl Cancer Centre Radiotherapy, Thumbs Up Antrim Area Hospital, Clinical Nurse Specialist, Head and Neck Nl Cancer Centre, Leukaemia Clinical Nurse Specialist, Haematology Gynae Oncology Clinical Nurse Speclallsl, Gynaecology Surgery, Belfast City Hospital O¢cupational Therapy, Pressure Reducing Cushions Gynae & Rectal Patients Teenage & Young Aduh Social Worker, Nl Can¢8r Centre Clinical Nurse Speclallst Programme Clinical Nurse Specialist, Teenage & Young Adults Cllnlcal Nurse Specl811sl. Teenage & Young Adults Scholarship, Pamela Lutton Scholarshlp, Pearl Ewing Scholarship, Dr Gary McGowan Tralning x 2, QA Praclilioner & Cllnical Nurse Specialist, Head & Néck 3.549 20,852 22.245 40,724 22,487 996 5,144 1,693 32,325 150 32,562 37,259 22,457 1,362 26,196 66,828 31,898 31,935 2,000 1,989 2,000 1,000 407,651 Cam al Campalgns 24,184 24,184 1,165,205
FRIENDS OF THE CANCER CENTRE DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Financial rovlew The net movement of funds amounted to incoming of £153,364, of which £172,608 incoming related to unrestricted actlvltles and £19,244 outgoing related to restrldéd funds. The Charity is involved in various fund- raising activities to provide adequate resources to meet ils objectives. The Directors are very pleased with the total income generated of £1,677,544 in the year in relation to the £127.384 expended on fundralsing and £66,374 on admlnlstratÉon. At 31 March 2024 the Charity had unrestricted reseNes of £3,524,246 of which £3,470,503 has b66n committed to support continuing activltles within thè Cancer Centre. The free uncommitted balan of funds is £53,743. Re8ervès poll¢y The Directors. Informed by the risk reglster. op8ratlng budget and known commitm8nts and Ilabllllles, have established a pollcy for the general reserves held by the Charoly. The organisatlon is entirely dependent upon Iluctualing donor funding from year to year, and it requires protection against and th8 ability to continue despite, a d¢)wntum in income. General ReseNe: the directors bellevè that the mlnlmum level of general r8seNes should be the equivalent of six months, operating costs and six months. commitments calculated and reviewed annually and believe that the réserves should be built up to the desired lev81 in stages conslslent with the Charity's overall financlal position and its need lo maintain and develop its charitabl8 actlvlll8S. Designated Reserves.. To enabl8 the Charity lo support projects and research posts whlch cover more than on8 year the directors designate those funds for which grants have been commltted or approved for a period of up to 2 years from the period end. The dlrectors are of the oplnion that approximately £950.000 of deslgnated funds would fall due for payment In the 6 months from the balance sheet date.
FRIENDS OF THE CANCER CENTRE DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 structure, governanco and management The Charity Is a company limited by guarantee and does not have a shara capital. It is governed by a Mèmorandum and Articles of Association and the liability of each member is limited to an amount not exceeding £1. The directors must offer their resignation after hvo years bul can make themselves available for re-election In accordance with the Articlés of Associalion. There werè 15 directors serving during the period up 10 31 March 2024. New Dlrectors are appolnted by the Board. The aim of the recruitment proc8ss Is to appolnt th8 most suitable person for the position of Director. Recruitment of new Directors will take into account the Charity's need for new ideas and fresh 8pproa¢hes. Th& last skills audit was Carrled out in 2024 and Is periodically revlewed by the Board. The Dlr8Ctors who served durlng the year and up to the date of slgnature of the flnancial statements w8r8: Mr B Cave Dr P Scullin Ms C Aiken Dr D Finnegan Prof S Jain Mr R Donnan Ms C Keenan Dr S McAleer ProfAAdalr Mr P Mcmaw Mr J Rice Prof M Durkin Mr Brian Fee Mr D Cubbitt Dr Caroline Forde (Reslgned 24 Novemb8r 2023) (Appointed 9 June 20231 (Appointed g June 20231 {Appointed 15 September 2023) (Appointed 23 February 2024) Audltor Harbinson Mulholland have indicated thelr wlllingness to contlnue in office. D18closuro 01 informatlon to audltor Each of the Oirectors has confirmed that Ihere is no Informatlon of which ihey are aware whlch Is relevant to the audit. but of which the auditor is unaware. They have further confirmed that they have taken approprlate steps to Identify su¢h r81evant information and to 8slabllsh that the auditor is aware of suGh information, Thls report has been pr8pared in accordance wlth sp8clal provision of Part 15 of the Companles Act 2006 relating to small companies. The Directors, report was approved by the Board of Directors. Caroline Keenan INOV 19, 2024 14..07 GMT) Ms C Keenan Director Dated.. 22 November 2024
FRIENDS OF THE CANCER CENTRE STATEMENT OF DIRECTORS. RESPONSIBILITIES FOR THE YEAR ENDED 31 MARCH 2024 Thè directors. who also act as tTUStees, are responslble for preparing the Directors, Report and the financial statements in accordance with applicable law and regulation. Company law requires the Directors to prepare financial statements for each financi81 year. Under that law the Directors have PrePad the financial slalements in accordance wrth United Klngdom Accounting Standards, comprising FRS 102 "Thè Financial Reporting Standard applicable in the UK and Republic of Ireland", and applicable law (United Kingdom Generally Accepted Accounting Practice}. Under company law the Directors must not approve the financial statements unless thèy are satisfied that they give a true and fair view of the stste of the affairs of the and of the incoming resources and application of resources, including the incom8 and expenditure, of the for thal period. In preparing th8se ffinan¢ial statements. the Directors are required to; select suitable accounting policies and then apply them consislently; observe the methods and principles in the Statement of Recommended Practl¢e.' Accounting and R8POrtlng by Charilles {2015)', make judgménts and estlmales that are reasonable and prudent,. and prepare the financi81 statements on the going conrn basis unless It Is Inapproprlate to presume that the will continue in business. The Dlrectors are responsible for keeplng adequate accounting records that are suffici8nt to show and explain the company's transactions and disdose wllh reasonable accuracy at any tlme the financial position of the company and enable them to ensure that the company comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the pVentIon and detection of fraud and other irregularities. In certain circumstances clients may choose to include an additional staternent here which is requlred to be made within thè direclors, report as a result of Sectron 418 of the Companies Act 2006. In accordance with Section 418, directors, reports shall include a stat8m8nt, in the case of each director in offic8 at the date the directors, report is approved, that: (a) so far as the trustee is aware, there is no relevant audit informatlon of which the company's auditors are unaware., and (bl they have taken all the steps that they ought to have taken as a trustee In order to make themselves aware of any relevant audit information and to establish that the Company's auditors are aware of that informatlon. By order of the Board of Directors ol lié Eegha Caroline Keenan (Nov 19, 2024 14:07 GMTI Ms C Keenan Dlreclor 22 November 2024
FRIENDS OF THE CANCER CENTRE INDEPENDENT AUDITOR'S REPORT TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE Oplnlon We have audited the financial statements of Frionds of the Cancer Centr8 Ilhe 'Charity') for the year ended 31 March 2024 which comprise the statement of financial activities, the statement of financial position. the slalemenl of cash flows and the notes lo the financial statements. including significant accounting policies. The financial reporting framework that has been appliad In their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financi81 Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion, the financial statements: give a true and fair view of the statè of the charitable company's affairs as at 31 March 2024 and of its incomlng resources and application of resources, for the year then ended; have been properly prepared in accordance with United Kingdom Gènerally Accepted Accounting Practice" and havè been prepared in accordance with the requirèments of the Companies Act 2006. Basls for oplnion We conducted our audit In accordance with International Standards on Auditing (UK) IISAS (UK)) and applicable law. Our responsibllllies under those standards are further described In the Auditorfs responsibilitles for the audit of the financial stalements section of our report. We are Indep8ndent of the Charity In accordance wlth the ethical requirèments that 8re r8levant to our audit of the flnancial statements In the UK, including the FRC'S Ethical Standard. and we have fulfilled our other ethical responsibiliti8s in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate lo provide a basis for our opinion. Concluslons relatlng to going concern We have nothing to report In respect of the following matters in relation to whlch the ISA5 (UK) require us to report lo you were.. the directors, use of the golng concem basls of accounting in the preparation of the financlal stslements 1$ not appropriate; or the directors have not disclosed in the financial statements any identified material uncertainties thal may cast significant doubt about thè group's or the parent company's abillty to continue to adopt the going ncem basis of accounting for a period of at least e1ve months from the date when the financial statements are authorised for issue. Other infomiatlon The other information mPriseS the information included in the Directors, Report, other than the finan¢lal statements and our auditor's report thereon. The directors are responslble for the other information. Our opinion on the financlal statements does rt cover the other information and. except to the extent otherwis8 explicitly stated in our report, we do not express any form of assuran conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the olher infomation and. in doing so, consider whether the other infomiation is materially inconsistent with the financlal statements or our knowledge obtained in the audit or otheiSe appears to ba materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude thal there is a materlal misstatement of this other infomiation, we are requlred to report that fact. We have nothing to report in this regard.
FRIENDS OF THE CANCER CENTRE INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE Oplnlons on other matters prescribed by the Companies Act 2006 In our opinion, baséd on the work undertaken in the course of our audit: thè information given in the Directors, report, which includes thè directors, report prepared for the purposes of company law, for the financial year for which the financial statements are prepared is conslstant wlth the financial statèmgnts., and the directors, report included withln the Directors, report has been prepared in accordance with applicabl8 legal requirernents. Matters on whlch w• ar• required to rnport by •xeèption In the light of the knowledg6 and understanding of the Charllable company and Its envlronment obtained in the cours8 of the audit, we hav8 not identlfied material misstatements In the Strategic Report and Ihe Dlredors, Report. We have nothing to report In respect of the followlng matters in relation to which th8 Charitles (Accounts and Reports) Regulatlons 2008 require us to report to you if, in our opinion- adequate aGcounting records hava not been kept or returns adequate for our audit have not been recelv8d from branches not visited by us., or the financlal statements are not In agreement with the accountlng record5 and turns,. or certain disclosures of trustees, remuneration speclfied by law are not made., or we have not received all the informatlon and explanations we require for our audlt. Responsibllltles of Dlrectors As exp18ined more fully in the statement of Directors, responsibilities, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give 8 true and fair vièw, and for such internal control as the Directors determine Is necassary to enable the preparatlon of financi81 statements that are free from fflaterlal rnisslatement, whether due lo fraud or error. In prep8rlng the financial statements, the Directors are rosponsible for assessing the Charity's abilty to conllnue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so. Audttorfs responslbilitlbs for the audlt of the flnanclal statsments Our objectives are to obtaln r8asonabl8 assurance about whether the flnanclal Statements as a whole are fre8 from material misstat8ment, whether due to fraud or error, and lo issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAS (UK) will always dètect a material misslatemenl when it exists. Misstatomenls can arise from fraud or error and are considered materlal If, individually or in the aggre9ate, they could reasonably be 8xpecled to influence the economic decisions of users taken on the basls of these financial statements. A further des¢rlpiion of our responslbllities Is available on the Financlal Reporting Council's w8bslle at.. httPS:/I www.frc.org.ukjauditorsresponsibilities. This description forms part of our auditols report.
FRIENDS OF THE CANCER CENTRE INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE Our approach to identifying and assessing the risks of material misststement in respect of irregularitles, including fraud and non-compliance wlth laws and regulations, was as follows.. the engagement partner ensured that the engagement team collectively had the approprlale competence, capabilities and skills lo identify or recognise non-compliance with applicable laws and regulations,. we identlfied the laws and regulations applicable lo the company through discussions with directors andlor senior management, and from our commercial knowledge and experience of the s6ctor: We focused on specific laws and regulations which we considered may have a dlrect material Èffect on the financial statements or the operatlons of the company, Including Companles Act 2006, taxation legislation, data protection, anti-bribery, employment, environmental and health and safety legislation we assessed th8 extent of Compliance with the laws and regulations Identifi8d above through maklng enquiries of management and inspectlng legal wrrespondence; and Identified laws and regulallons were communicated withln the audit team regularly and the team remalned alert to instances of non-compliance throughout the audit. We assessed the susceptibllity of the company's financial 5tatem8nls to material mlsslatement, includlng obtalning an understanding of how fraud might occur, by.. making enquiries of management as to where they conSided there was susceptiblllty to fraud. their knowledge of actual, suspected and alleged fraud,. and considering the Internal controls in place to mitigate risks of fraud and non<ompliance with laws and regulations., To address the risk of fraud through management bias and overrlde of controls, we: performed analytical procedures to Identity any unusual or unexpected relationships. tested journal entries to idenlify unusual transactions., assessed whether judgements and assumptions mad8 In determining the accountlng estimates set out in Note 2 were Indicative of poienlial bias., and investigated the rattonale behind significant or unusual transactlons., In response to the risk of Irregularitie5 and non-compliance with laws and regulation8, we designed procedures which included, but were not limiled to: agreeing financial slalement disclosures to underlying supportlng documentation; reading the minutes of meetings of those charged with govemance- enquiring of managemenl as to actual and potential litigation and claims,. and reviewing Correspondence with HMRC and the company's legal advisors., There are Inherent Ilmilalions in our audit procedures described above. The more removed that laws and regulations are from financial transaction5. the less likely il is that we would become aware of non-compliance. Auditing standards also limit the audrt proCedUS required to identify non<ompliance with laws and regulations to enqulry of the dire¢lors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
FRIENDS OF THE CANCER CENTRE INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE This report is made solely to thè charitsble company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audlt work has been undertaken so that we might stste to the parent charitable company's members those matters we are required to state to them in an audltols réport and for no other purpose. To the fvllesl extent permltted by law. we do not accept or assume responsibility to anyone other than the company and the charitable company's members as a body, for our audit work, for this report, or for the oplnions we have fonned. fciA Angela Craigan Isenlor Statutory Audltor) for and on behalf of Harblnson Mulholland Chartered Accountants Statutory Audltor Centrepoint 24 Omieau Avenue Belfast Co. Antrlm BT2 8HS 2211112024 Harblnson Mulholland is eligible for appointment as auditor of the Charity by vlrtue of its eligiblllty for appointment as audltor of a company undèr of sectlon 1212 of the Companies Act 2006.
FRIENDS OF THE CANCER CENTRE STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 MARCH 2024 Unrestricted Restricted funds funds 2024 2024 Tolal Total 2024 2023 Notos Incomé from: Donations and legacies Investments 1,361,754 115,463 200,327 1,562,081 115.463 1,612,179 63,249 Totsl Incom• 1,477,217 200.327 1,677,544 1,675,428 endlturè on: Charitable activities 1,383,111 219,571 1,602,682 1,627,157 Net gaing1(lossesl on Investments 78.502 78,502 187,390) Net Incomel(expendlturn) for the yearl Nel movemant in funds 172,608 (19,2441 153,364 (39,1191 Fund balances at 1 April 2023 3,351,638 46,209 3.397,847 3,436,966 Fund balances at 31 March 2024 3,524,246 26,965 3,551,211 3,397.847 Th8 Statsment of financlal actIlIeS Includes all galns and losses recognlsed in the year. The statement of financial actlvltles Includes all gains and losse8 r8cognised in the year. All Income and expenditure derive from continuing actlvities. Thè statement of financl81 actlvities also complles wlth the requirements for an Income and expendlture account under the Companies Act 2006. The notes on pages 14 10 24 fom part of these financSal statements, 10-
FRIENDS OF THE CANCER CENTRE STATEMENT OF FINANCIAL POSITION ASAT31 MARCH 2024 2024 2023 Notes Flxod assets Tangiblé assets Investments 11 12 1,334 1,214,125 1.594 1,135,623 1,215,459 1,137,217 Current assets Debtors Cash at bank and In hand 13 48.992 2,504.936 31.343 2,267,691 2,553,928 2,299,034 Credltor8: amount8 falllng duo wlthln one yoar 14 {218,1761 {38,404) Net current assets 2,335,752 2,260,630 Total assets less curront Ilabilltlas 3,551,211 3,397,847 Income funds Restricted fund5 Unrestricted fund Designated funds Gener81 unrestrlcted funds 15 26,965 46,209 16 3,470,503 53,743 3,288,368 63,270 3,524,246 3,351,638 3,551,211 3,397.847 'Please refer to page 3 for further information on unrestricted and deslgnated funds 11
FRIENDS OF THE CANCER CENTRE STATEMENT OF FINANCIAL POSITION (CONTINUED) ASAT31 MARCH 2024 Thè company is entitled to thè èxemption from the audlt requirement contained in section 477 of the Companies Act 2006, for the year ended 31 March 2024, although an audit has been carried out under sédlon 65 of the Charltles Act (Nl) 2008 . The director acknowledges her rèsponsibilities for ensuring that the charity keeps accounting records whlch comply with sectlon 386 of the Act and for preparing financlal statements which give a true and fair view of the state of affairs of the company as al the end of the financial year and of its Incoming resources and application of resources, including its income and expendllure, for the financial year in accordance with thé requirements of sections 394 and 395 and which otheise comply with the requirements of the Companies Act 2006 relating to financlal statements, so far as applicable to the company. Th8 members have nol required the company to obtaln an audit of Its financlal statements under the requirements of the Compan185 Act 2006, for the year In question In a¢¢ordance wlth section 476. These financial stat8m8nts have been prepared In accordance wlth the provlsions appllcable to companles sublect to the small companies regime. The financlal statements were approved by the Directors on 22 November 2024 FiGh Donk7 Brian Cave (Nov 21, 2024 13.'39 GMT) Mr B Cave Dlr8ctor Richard Donn3n (Nov 19, 2024 13.'44 GMT) Mr R Donnan Dlrector Company registratlon number N1616925 12-
FRIENDS OF THE CANCER CENTRE STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH 2024 2024 2023 Notes Cash flows from operatlng actlvlties Cash generated froml(absorbed by) operations 21 122,180 (36,854) Investlng aclivitie8 Purchase of tangible flxad assèts Proceeds from disposal of tanglble fixed assets Investm8nt Income received (398) (1,794) 159 63,249 116,463 Net cash generated from Invostlng acllvlllg8 115,065 61,614 N•1 cash yd In flnanclng actlvltles Net Incroa8e In cash and cash equlvalonts 237,245 24.760 Cash and cash equivalents at beginnlng of year 2,267,690 2,242,930 Cash and cash equlvalent8 at end of year 2,504,936 2,267,690 13-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 Accountlng pollcies Charlty informatlon Friends of the Cancer Centre is a privale company liffllted by guarantee incorporated in Northern Ireland. The registered office is N.1. Cancer Centre, Belfast City Hospital, Lisbum Road, Belfast, Co. Antrim, BT9 7AB. 1.1 Accounting convention The financial statements have been prepared in accordance with the Companies Act 2006 and °Accounting and Reporting by Charities: Statemènt of Recommended Practice applicable to charities preparing their accounts in accordance wilh the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 102). las amended for accourbting periods commencing from 1 January 2016). The Charity Is a Publlc Benefit Entity as defined by FRS 102. The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary amounts in these financial statements are rounded to th8 nearest £. The finan¢i81 statements have been prepared under the historical cost conventlon, modified to include the revaluation of freehold properties and to include investment propèrtles and certain finandal Instruments at fair value. The prlnclpal accounting policies adopted are set out below. 1.2 Golng concern At the lime of approving the financial stat8menls, the Directors have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. Thus the Directors continue to adopt the going concern basis of accounting In preparing the financial statements. 1.3 Charitable funds Funds hèld by the Charity are eith8r. Unrestricted general funds these are funds whlch can be used in accordance wlth the charitable objects at the discretion of the directors. Designated funds - these are funds Set asld8 by the directors out of unr8Stricted general funds for specific futur8 purposes or projects. Restricted funds - these are funds that can only be used for particular restricted purposes within the objects of the Charity. Restrictions arise when specified by the donor or when the funds are raised for particular restricled purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financlal statements. 1.4 Income Income Is recognised in the period In which the Charlty is entitled to recelpt and the amount can be measured with reasonable cèrtainty. Income is deferred only when the Charity has to fulfil condltions before becoming entitled to it or where the donor has specified that the income is to be expended in a future period. Voluntary income is received by way of donations and gifts and is included in full in the Statement of Financial Activities (SOFA) when receivable. Income received from activities for generating funds are included when collecled. Investment income is included when receivable. Donated facilities are Included at the value to the Charity where this can be quantified and a third party Is bearing the cost. No amounts are included in the financial statements for serviGes donatsd by volunteer5. 14-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Accountlng policies (Continued 1.5 Expenditura Expenditure is included in the Statement of Financial Activities (SOFA) on an accruals basls, inclusive of any VAT which cannot be recovered. Costs of generaling fvnds comprise the costs associated with attracting voluntary income. Charitable expenditure comprises those costs incurred by the Charity in the dellvery of its activities and services for its beneficiaries. It includes both costs that can b6 allocated directly to such activities and those costs of an indirect nature necessary lo support them. Governan costs include those costs associated with meeting the constitutional and statutory requirements of the Charity and include the audit fe8s and costs linked to the strategic management of the Charity. All costs are allocated befvéeen the expendlture categorles of the SOFA on a basis designed to reflect the use of the resource. Costs relatin9 to a particular activity are allocated directly. others are apportioned on an appropriate basis e.g. staff time and floor space as set out in Note 6. 1.6 Tanglble tlxod assets Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, nel of depreciation and any impairment losses. Depreciation is recognised so as to write off the Cost or valuation of assets less their residual values over their useful livas on the following bases.. Fixtures and flttings Computers 15Yo Straight line 250h straight Ilne The gain or loss arising on the disposal of an asset is determined as the differenc8 between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities. 1.7 Flxod asset invèslments Fixed asset investments are initially measur8d at transaction prlce excluding transaction costs, and are subsequanlly measured at fair valué at each reporting date. Changes in fair value are recognised in net incomellexpenditurèl for the year. Transaction ¢osts are expensed as Incurred. 1.8 Impalmient of Ilxed assèts Al each reporting end dale, the CharTty revlews the carrylng amounts of its tangible assets to det8rmlne whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amounl of the asset 1$ estlmaled in order to determine the extent of the impaimient loss (rf any). 1.9 Cash and cash aqulvalents Cash and cash equivalents include cash in hand. deposits held at call wlth banks. other short-term Ilquld investments with orlginal maturities of three months or les5. and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 1.10 Flnancial Instruments The Charlty has eleded to apply the provi5i0ns of Section 11 'Basic Financial Instruments, and Section 12 'Other Financial Instruments Issues, of FRS 102 to all of its financial instruments. Financial instruments are recogni5ed in the Charivs balance sheet when the Charily becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to sel off the recognlsed amounts and there is an intention to settle on a nel basis or to realise the asset and settle the liability simultaneously. 15-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Accounting pollcle8 (Continued) Basic financial assots Basic financial assets, which Indude debtors and cash and bank balances, ar6 Initially measured at transaction pricè including transaction costs and are subsequently carried at amortised cost using the effective interest method unlèss the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assèts classified as receivable within one year are not arnortised. 8aslc flnanclal Ilabllitlos Basic financial liabilities, including creditors and bank loans a initially recognlsed at transactlon prlce unless the arrangemenl constitut8s a financing Irans8cts'on, where the debt instrument Is measUd at the present value of the future payments discounted at a market rat8 of interest. Financial liabilities classlfied as payable within one year are not amortised. Debt instrum8nts ar8 subsequently ¢arrl8d at amortlsed cost, using the 8ffective interest rate method. Trade creditors are obligatlons to pay for goods or servlc8s that have been acquired in the ordlnary course of operations from suppliers. Amounts payable are classified as current liabilities rf payment is due within one year or less. If not, they are presented as non-current Ilabilities. Trade creditors are recognised inltlally at transaction price and subsequently maasured at amortised cost uslng the effective interest method. Derecognltlon of flnanclal Ilabllltles Financial liabilities are derecognis8d when the Charity's contractual oblsgations expire or are discharged or cancelled. Crltlcal accountlng estlmates and Judgements In the application of the Charlly's accounting pollcles, th8 Directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparént from olher sources. The estimates and associated assumptions arè based on historical experience and other factors that a consideréd to be relevant. Actual results may differ from thesè estimates. The estimates and underlying assumptions are revlewed on an ongoing basis. Revisions to accounting estimates are rècognised in the perlod in which the estimate is revised where the revision affects only that period. or in the perlod of the revision and fulure periods whére the revision affects both currenl and fulure periods. Crftlcal judgement8 Impalrmont and depreclation Long-lived assets comprising primarily of computer equipment. The annual depreciation charge depends primarily on the estimated lives of each type of asset and, in certain circumstances, estimates of residual values. The directors regularly review these useful lives and change them if necessary to reflect current conditions. In determining these useful lives management consider technological change, patterns of consumption. physical condition and expeded economic utslisation of the assets. Changes in the useful Ilves can have a signiflcant impact on the depreciation charge for the financial year. The net book value of tangible fixed assets subject to depreciation at the financial year end date was £1,334 (2023.. £1,594). 16-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Donations and legaclos Unrestrictod Restrfcted funds funds Total Unrestrictsd Restrlctsd fvnds funds Total 2024 2024 2024 2023 2023 2023 Donatlons and gifts Grants 1,361,754 162.127 38,200 1.523,881 38,200 1,390,345 189,631 32.203 1,579,976 32,203 1,361,754 200,327 1,562,081 1.390,345 221,834 1,612,179 Donatlons and glfts Supporter Events G8neral Donations Corporate Donations Friends Groups Frlends Events Legacies In lieu of flowers Organisations HMRC GiftAid Merchandise other 325,838 269,785 209,632 23,660 245,198 59,462 110.363 15,875 89.518 6,432 5,991 325,838 269,835 278,344 25.700 250,298 59,462 110,987 15,875 90,119 6,432 90,991 360,537 236,870 153.674 12,173 307,135 98.023 129,225 11,635 70,974 4,741 5,358 1,000 4,514 56,190 361,537 241,384 209,864 12.173 309,578 98,023 131,340 63,935 72,043 4,741 75,358 50 68,712 2,040 5,100 2,443 624 2,115 52,3CNJ 1,069 601 85,000 70,000 1,361,754 162,127 1,523,881 1,390,345 189,631 1.579,976 Other Income Includes £4,000 (2023.. £4,000) ol donated s8rvIS and facilities which comprise the provislon of office space and administration services. A corresponding amount is included wlthln the cost of charitable activitles. Grants rècèlvablo for coro actlvltles Community Foundation Nl Dormant Account Fund 6,000 6,000 32,200 32,200 32,203 32,203 38,200 38,200 32,203 32.203 17-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Income from Investments Unrnstrlcted Unrestricted funds funds 2024 2023 Investment income 115,463 63,249 Charltabla actlvltles 2024 2023 Research projects Patient rnfort Patlent care Project support FurKlraislng Administratlon Campaigns 423,471 309,899 407,651 220,377 127,384 66,374 24,184 397,155 318,261 388,710 229,762 162,349 76,461 32.388 1.579,340 1,605,084 Share of support costs (see note 6) Share of governance Costs (see note 6) 19,842 3,500 18,573 3,500 1,602,682 1,627,157 Analysls by fund Unrestricted funds Restricted funds 1,383,111 219,571 1,373,885 253.272 1,602,682 1,627,157 18-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Support costs Support Govemance costs 2024 Support Governanco costs costs 2023 Insuran Rent, electrlcity gnd telephone Fundraiserfs expenses Bank fees Legal and profession81 expenses Depreciation 2.555 2,555 2,847 2,847 4,000 7.885 2,010 4,000 7,885 2.010 4,000 6,293 1,938 4,000 6,293 1.938 2,733 658 2,733 658 2,294 1,201 2,294 1,201 Gov8rnanc8 Costs 3,500 3,500 3,500 3.500 19.841 3.500 23.341 18,573 3,500 22,073 Analysed beeen Charitable activities 19,842 3,500 23,342 18,573 3,500 22,073 Dlrectors None of the Directors lor 8ny persons connected wlth them) received any remuneration or benefits from the Charity during the year. Employees The average monthly number of employeès during the year was.. 2024 Number 2023 Numbor Admlnlstratlon Directors 15 12 Total 24 21 Employmont costs 2024 2023 Wages and salaries Social securily costs Other pension costs 296,337 21,365 22,610 307,765 27,936 25,309 340,312 361.010 19-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Employees (Contlnued) There was no employee wlth emoluments in excess of £60,000 per annum (2023.. 1). The totsl amount of employee benefits recelved by key management personnel in the period was £164,211 12023: £219,772). The key management personnel of the Company comprises 3 members of staff (2023.. 4). the CEO, Finance & Admlnlslration Manager and the Communications & Projecl Manager. Net galn81(losses) on Investmènts Unrèstrlct funds Total 2024 2023 R8valuation of investm8nts 78,502 (87,390) 10 Taxatlon The charity is exempt from taxation on its actlvltles because all its incom8 is applied for charitable purposes. 11 Tanglble flX assets FlxtuTM und Comput•r• flttlngs Total Cost At 1 Aprfl 2023 Addllions 1,572 14,175 398 15,747 398 At 31 Mah 2024 1,572 14,573 16,145 Depreclatlon and Impalrment Al 1 April 2023 Depreciation charged in the year 1,572 12,581 658 14,153 658 At 31 March 2024 1,572 13,239 14,811 Carrylng amount At 31 March 2024 1.334 1,334 At 31 March 2023 1,594 1,594 -20-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 12 Flxed asset investments Llsted Invèstments Cost or valuatlon At 1 April 2023 Valuation changes 1,135,623 78,502 At 31 March 2024 1.214.125 Carrylng amount At 31 Mar¢h 2024 1,214.125 At 31 March 2023 1,135,623 The Investments ar8 held as part of the North8m Ireland Central Investment fund for Charities. The Investments are held at Market Value. 13 Debtors 2024 2023 Amounts falllng duo wlthln ono yaar. Other debtors Prepayments and accrued Income 46,243 2,749 28,474 2,870 48,992 31,344 14 Credttor8: amounts falllng duo wlthln one year 2024 2023 Other creditors Accruals and deferred income 166.205 51,971 20.424 17.980 218.176 38,404 21
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 15 Restrictad funds The restrictéd funds of the charlty comprise the unexpended balances of donatlons and grants held on trust subject to specific conditions by donors as to how thèy may be used. Movemènt In funds Incomlng Resour¢•s Balance at r•sour¢o5 •xponded 31 March 2024 Balance at 1 Aprll 2023 Research Patient Care Patient Comfort Grants recelved 20,871 127.982 13,274 38,200 120,871) {133,9171 113,274) (51,5091 10.357 11,875 23,977 4.422 11,875 10,668 46,209 200,327 1219,5711 26,965 RestrlGted funds are legacie5 and donations received for sp8cifi8d purposes withln the overall aims of the Charity. Funds recelved for research are used to support cancer research in the centre. Induded withln Clinical care is £48,442 received from Applegreen Plc. This partnèrship works to provide support for the Centre's Teenager and Young Adult Programm8, funding vital nursing hours for teenagers and young adults with support durlng and after treatment. -22-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 16 Da8ignated funds The unrestricted funds of the charity compris8 the unexpended balances of donations and grants which arè not subject lo specific condltlons by donors and grantors as to how they may be usèd. These include designated funds which have been set asid8 Out of unrestricted funds by the trustees for specific purposes. Balance at 1 Aprll 2023 Ré8ourc•$ èxpended Transfern Balance at 31 March 2024 Research Patient Care Patlent Comfort Campalgns 791,296 1,958,666 538,404 1423.470) 1309,900) 1407,651) 124,184) 101,207 784,427 397,525 64,184 469,033 2.433,193 528.278 40,000 3,288,366 {1,165,2051 1,347,342 3,470,503 Many of the projects funded by the Charity span several years. For example, a research project post may be approved for more than one year or, th8 purchase of equipment may requlre a maintenancé contract. To recognlse Ihese future commitments and ensure that there are unexpected interruptions In the funding of the work supported by the Charity, the directors designate the funds needed for the next year of the project. For some specific prolects two years of required funds have been designated. Designated funds are not restricted by nature. 17 Analysls of not assets botween funds Unrestrlcted Restrlcted funds funds 2024 2024 Total Unrestrlcted Restrictèd funds funds 2023 2023 Total 2024 2023 Fund balances 8131 March 2024 are represented by.. Tangible assets Investrnenls Current assetsl{liabilities) 1,334 1,214,125 2,308,787 1,334 1,594 1,214.125 1,135,623 26.965 2.335,752 2,223,013 1,594 1,135,623 37,615 2,260.628 3,524,246 26,965 3,551,211 3,360.230 37,615 3,397,845 18 Rellrement bonoflt schemes Defined contrlbution Schemes The Charity operates a defined contrlbution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of thè Charity in an independently administered fund. The pension cost and charge represents contributions payable by the company to the fund and amounts to £22,610 (2023: 25,309). 19 Financlal commitments, guarantees and contingent liabilttles There were no financial commitments at the balance sheet date over and above monies in designated funds. -23-
FRIENDS OF THE CANCER CENTRE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 20 Related party transactlons There were no di5closable related paty transactions during the year {2023 - none). 21 Cash generated from operatlons 2024 2023 Surplusl(deficit) for the year 153,364 139,119) Adjustments for.. Investment income recogn15ed in statement of linancial activities (Gain}Iloss on disposal of investments Depreciation and impairment of tangible fixed assets 1115,463) (78,502) 658 163.249) 87,390 1,200 Movements in working capital.. Ilncreasel in debtors In¢r8aselldecr8asel in creditors 117,6491 179.772 (9,5941 113.482) Cash generat•d froml(absorbed by) operatlons 122,180 136,854) -24-